Adverse events associated with oseltamivir and baloxavir marboxil in against influenza virus therapy: A pharmacovigilance study using the FAERS database

不良事件报告系统 奥司他韦 药物警戒 不利影响 医学 数据库 内科学 重症监护医学 2019年冠状病毒病(COVID-19) 传染病(医学专业) 疾病 计算机科学
作者
Y. Zhou,Liuyin Jin,Xinxing Lai,Yang Li,Sheng Liu,Guoming Xie,Jianwen Fang
出处
期刊:PLOS ONE [Public Library of Science]
卷期号:19 (11): e0308998-e0308998 被引量:4
标识
DOI:10.1371/journal.pone.0308998
摘要

Background Influenza virus is a widespread pathogen that poses significant health risks to humans. Oseltamivir and Baloxavir Marboxil are commonly utilized medications for both treating and preventing influenza infections. Despite their widespread use, there remains a need to thoroughly investigate their safety profiles and potential adverse reactions. Objective This study aims to comprehensively analyze the adverse events associated with oseltamivir and baloxavir marboxil in real-world clinical settings, with the goal of assessing their safety and potential risks in the management of influenza virus infections. Methods We conducted a retrospective analysis utilizing data from the Food and Drug Administration Adverse Event Reporting System (FAERS) database, spanning from the first quarter of 2004 to the third quarter of 2023. The analysis encompassed examination of drug utilization patterns, types of adverse events reported, patient demographics, and other pertinent factors. Results From the first quarter of 2004 to the third quarter of 2023, FAERS collected over 17,035,521 adverse event reports (AE reports). Among these reports, there were 38,384 reports associated with oseltamivir, and 3,364 reports associated with baloxavir marboxil. Oseltamivir and Baloxavir Marboxil were primarily used for the treatment of influenza virus infections, accounting for 62.43% and 67.49% of their total usage, respectively. The main adverse reactions reported for oseltamivir were vomiting (case reports = 1402) followed by confusional state (case reports = 353), while for baloxavir marboxil, adverse reactions mainly centered around off-label use (case reports = 378) and intentional product use issues (case reports = 278). In terms of systemic adverse reactions, oseltamivir primarily affected psychiatric disorders (n = 45), whereas baloxavir marboxil mainly impacted the gastrointestinal system (n = 7). Additionally, regarding adverse reactions in pregnant women, the occurrence of normal newborns was a significant signal for oseltamivir, suggesting a certain level of safety during maternal use. Conversely, reports of adverse reactions such as respiratory arrest were documented for baloxavir marboxil, while no such reports were associated with oseltamivir. Conclusion This study provides a comprehensive analysis of the adverse reactions observed with the clinical use of oseltamivir and baloxavir marboxil, revealing the safety and risks associated with these two drugs in the treatment and prevention of influenza virus infections. Firstly, although both drugs are used for influenza treatment, they exhibit different types of adverse reactions. Oseltamivir predominantly affects the psychiatric system, while baloxavir marboxil primarily impacts the gastrointestinal system. Additionally, oseltamivir demonstrates a certain level of safety for use in pregnant women, while reports of adverse reactions such as respiratory arrest are associated with baloxavir marboxil. Despite the clinical significance of this study, limitations exist due to the voluntary nature of data reporting, which may lead to reporting biases and incomplete information. Future research could employ more rigorous prospective study designs, integrating clinical trials and epidemiological studies, to more accurately assess the safety risks of oseltamivir and baloxavir marboxil.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
1秒前
郭芙蓉发布了新的文献求助10
2秒前
陈陈发布了新的文献求助10
2秒前
2秒前
2秒前
WHY发布了新的文献求助10
2秒前
月明星稀完成签到 ,获得积分20
4秒前
4秒前
小白发布了新的文献求助10
4秒前
pppl发布了新的文献求助10
5秒前
喝可乐也很好完成签到,获得积分10
5秒前
5秒前
王小茗发布了新的文献求助10
5秒前
Ava的应助被杨yang采纳,获得10
5秒前
小二郎的应助被故顾采纳,获得10
5秒前
Nicie发布了新的文献求助10
6秒前
6秒前
栗子完成签到,获得积分10
6秒前
6秒前
S.发布了新的文献求助10
6秒前
ding的应助被jason采纳,获得10
7秒前
che66发布了新的文献求助10
7秒前
海洲完成签到 ,获得积分10
7秒前
yuuu发布了新的文献求助10
7秒前
vary发布了新的文献求助10
7秒前
陈陈完成签到,获得积分10
9秒前
NexusExplorer的应助被失眠的含莲采纳,获得10
9秒前
10秒前
粗心小熊猫完成签到,获得积分10
10秒前
151515完成签到,获得积分10
11秒前
赘婿的应助被先玉梅采纳,获得30
11秒前
单杀是发布了新的文献求助10
11秒前
lilysmile001完成签到,获得积分10
11秒前
脑洞疼的应助被勤恳的丹翠采纳,获得10
12秒前
明理芫发布了新的文献求助10
13秒前
聪慧的稀发布了新的文献求助10
13秒前
zcyuqing发布了新的文献求助10
14秒前
田様的应助被luori_2000采纳,获得100
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8163407
求助须知:如何正确求助?哪些是违规求助? 9557533
关于积分的说明 21740746
捐赠科研通 7754041
什么是DOI,文献DOI怎么找? 3428210
关于科研通互助平台的介绍 2552932
邀请新用户注册赠送积分活动 2472896